ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

EBS Emergent Biosolutions Inc

3.88
0.58 (17.58%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Emergent Biosolutions Inc EBS NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.58 17.58% 3.88 09:00:00
개장가 저가 고가 종가 전일 종가
3.45 3.36 4.02 3.89 3.30
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202405:57GLOBEEmergent BioSolutions Reports First Quarter 2024 Financial..
02/05/202405:10GLOBEEmergent BioSolutions Announces Strategic Operational..
02/05/202400:03GLOBEEmergent BioSolutions Releases New Survey Findings..
01/05/202406:26GLOBEEmergent BioSolutions Announces Amendment to its Existing..
22/04/202421:05GLOBEEmergent BioSolutions to Release First Quarter 2024..
01/04/202421:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
28/03/202421:15GLOBEEmergent BioSolutions Continues to Broaden Access, Awareness..
25/03/202421:05GLOBEEmergent BioSolutions Receives NAI Status for Baltimore..
09/03/202406:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/03/202410:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:31GLOBEEmergent BioSolutions Reports Fourth Quarter 2023 Financial..
07/03/202406:15EDGAR2Form 8-K - Current report
06/03/202420:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
05/03/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202408:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202421:00GLOBEEmergent BioSolutions to Release Fourth Quarter & Full Year..
28/02/202410:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202410:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202421:25EDGAR2Form 8-K - Current report
21/02/202421:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
11/01/202421:41EDGAR2Form 8-K - Current report
09/01/202422:40EDGAR2Form 8-K - Current report
09/01/202421:30GLOBEEmergent BioSolutions to Present at the 42nd Annual J.P...
27/12/202320:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
12/12/202307:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/12/202321:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/11/202321:15EDGAR2Form 8-K - Current report
28/11/202320:59GLOBEEmergent BioSolutions Receives $75 Million Contract Option..
24/11/202321:30GLOBEEmergent BioSolutions Receives NYSE Notice Regarding Delayed..
24/11/202321:17EDGAR2Form 8-K - Current report
17/11/202306:11EDGAR2Form 8-K - Current report
15/11/202309:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202309:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202309:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202306:22EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/11/202307:38GLOBEEmergent BioSolutions Reports Third Quarter 2023 Financial..
09/11/202306:21EDGAR2Form 8-K - Current report
31/10/202305:45GLOBEUPDATE: Emergent BioSolutions to Release Third Quarter 2023..
19/10/202319:30GLOBEEmergent BioSolutions to Release Third Quarter 2023..
16/10/202320:00PRNUSEmergent BioSolutions Partners with Emmitt Smith to Launch..
06/10/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202308:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202308:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/10/202308:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/10/202320:42EDGAR2Form 8-K - Current report
02/10/202320:49EDGAR2Form 8-K - Current report
02/10/202320:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
30/08/202319:30EDGAR2Form 8-K - Current report
30/08/202318:59GLOBEEmergent BioSolutions’ NARCAN® Nasal Spray Launches Over the..

최근 히스토리

Delayed Upgrade Clock